Nov 17, 2022 / 03:15PM GMT
Kevin Strang - Jefferies Financial Group Inc. - Analyst
Hi. My name is Kevin Strang. I'm one of the biotech associates here at Jefferies. It's my pleasure today to introduce ESSA Pharma for a fireside chat. I have here with me, David Parkinson, CEO; Peter Virsik, the COO; and David Wood, the CFO. And it's going to be a fireside-chat format. And with that, thank you for joining us today, management.
David Parkinson - ESSA Pharma Inc. - President, CEO & Director
Appreciate the opportunity. Thank you, Kevin.
Kevin Strang - Jefferies Financial Group Inc. - Analyst
And so yeah, we can just dive in if you wouldn't mind telling me, for those who don't know as well, a little bit about ESSA Pharma, and maybe give us a one-minute intro highlighting your main products.
David Parkinson - ESSA Pharma Inc. - President, CEO & Director
Certainly, well ESSA is a small biopharma company focused on small-molecule development to inhibit androgen male hormone biology. That's particularly
ESSA Pharma Inc at Jefferies London Healthcare Conference Transcript
Nov 17, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers